Browsing Tag
Japan
223 posts
Why Dai Nippon Printing chose Hyderabad for its second overseas R&D hub as 7912 retreats from 52-week highs
Dai Nippon Printing (TSE: 7912) opens an IIT Hyderabad R&D base for EV wireless charging and pharma APIs. Read the full strategic analysis.
Hormuz crisis: 20-nation coalition ready to act as oil prices hit $126 a barrel
Twenty governments including the UK, France and Japan condemned Iran's Strait of Hormuz closure and attacks on commercial shipping in a joint statement on 19 March 2026.
Rocket Lab Corporation extends Synspective momentum as constellation demand lifts launch visibility (NASDAQ: RKLB)
Rocket Lab Corporation launched Synspective’s eighth StriX satellite. Read how the mission could deepen its edge in commercial and defense space markets.
US destroys 44 Iranian mine-laying vessels in Strait of Hormuz as oil crisis deepens
US forces have destroyed 44 Iranian mine-laying vessels near the Strait of Hormuz as Tehran's blockade triggers the worst global energy crisis since the 1970s.
Hormuz crisis: Six nations demand Iran end attacks and open strait to commercial shipping
UK, France, Germany, Italy, Netherlands and Japan condemn Iran's Strait of Hormuz attacks and call for compliance with UN Security Council Resolution 2817.
Japan February 2026 exports rise 4.2%, beating forecasts despite China and US slump
Japan's exports rose 4.2% in February 2026, beating forecasts, as Hong Kong and Southeast Asia offset sharp declines in shipments to China and the United States.
‘Not our war’: Germany, Japan, Italy flatly reject Trump’s Hormuz warship demand
Germany, Japan, Italy and Australia reject Trump's demand for warships at the Strait of Hormuz as the US-Israel war on Iran enters its third week.
How Kirin Holdings (2503.T) is taking HYOKETSU, Japan’s 15bn unit canned cocktail brand, into the U.S. market
Kirin Holdings launches HYOKETSU RTD cocktails in the U.S. via local production. What does this mean for competitors and the $50B global RTD market? Read more.
What Galderma’s Japan launch of Restylane Defyne and Refyne means for the Asia aesthetics market
Galderma launches Restylane Defyne and Refyne in Japan, expanding OBT injectables. Find out what this means for Asia growth and investors.
Eisai and Shanghai Henlius Biotech enter Japan-focused licensing pact for serplulimab as PD-1 competition tightens
Discover how Eisai Co., Ltd.’s serplulimab licensing deal with Henlius could reshape Japan’s PD-1 oncology market and investor expectations.